News

Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program

2 years ago

Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update

2 years ago

Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™

2 years ago

Jushi Holdings Inc. Amends and Refiles Q1 2022 Financial Statements

2 years ago

Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

2 years ago

Aleafia Health Inc. Announces Closing of $5.6M Private Placement

2 years ago

Century Therapeutics Announces Its Addition to the Russell Microcap® Index

2 years ago

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

2 years ago

Hepion Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders

2 years ago

Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 2022

2 years ago
Show more Posts
Show previous Posts